Cargando…
Use of remdesivir in children with COVID-19 infection: a quick narrative review
SARS-CoV-2 infection has a severe course in a small percentage of children. Remdesivir has shown promising results in reducing hospitalisation time in adults, but data on mortality rate are conflicting and few studies are available on its use use in antivirals in children. We performed a quick narra...
Autores principales: | La Tessa, Andrea, Motisi, Marco Antonio, Marseglia, Gian Luigi, Cardinale, Fabio, Licari, Amelia, Manti, Sara, Tosca, Mariangela, Del Giudice, Michele Miraglia, De Filippo, Maria, Galli, Luisa, Chiappini, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431884/ https://www.ncbi.nlm.nih.gov/pubmed/34842595 http://dx.doi.org/10.23750/abm.v92iS7.12396 |
Ejemplares similares
-
Tuberculosis and TNF-α inhibitors in children: how to manage a fine balance
por: Parigi, Sara, et al.
Publicado: (2020) -
Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5–11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
por: Novembre, Elio, et al.
Publicado: (2022) -
Allergy and COVID-19
por: De Filippo, Maria, et al.
Publicado: (2021) -
Biologic drugs in chronic spontaneous urticaria
por: Licari, Amelia, et al.
Publicado: (2021) -
Foreword
por: Caffarelli, Carlo, et al.
Publicado: (2020)